The different types of psychedelic drugs are classified into pharmacological classes. Classic psychedelics, which include LSD and psilocybin, and dissociative psychedelics, like ketamine and dextromethorphan, have different receptor effects that lead to behavioral and subjective effects.
Palliative care has recognized and addressed the issue of existential suffering, which has become increasingly important in providing quality end-of-life care. Through its focus on the subjective nature of suffering and the search for meaning, it provides a way for patients to find purpose and understanding, even in their final days.
Dr. Andrew Huberman and Matt explore the potential for psychedelic substances to open up a state of neuroplasticity, which can be directed towards a particular endpoint, and the current debate surrounding their use.
This podcast discusses the profound effects of the serotonin system and dopamine system, which are neuromodulators responsible for changing the behavior of other circuits in the body. Specifically, it delves into how psychedelics such as LSD and psilocybin target the serotonin system and increase the activity of particular receptors, leading to challenging preexisting models and predictions.
Psychedelic therapy has the potential to reshape the field of psychiatry as advancements in technology allow for new examinations of the mind and consciousness. High dose mushrooms can provide a therapeutic experience that shapes the brain based on positive and negative stimuli.
In this podcast episode, the host speaks with a guest about plant medicines, particularly ayahuasca, and how these teacher plants can communicate with humans in a way other plants cannot. The conversation also touches on psychedelic therapy and its potential to help with mental health issues.